Juntermanns B, Fingas C D, Sotiropoulos G C, Jaradat D, Dechêne A, Reis H, Kasper S, Paul A, Kaiser G M
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, Essen, Deutschland.
Klinik für Gastroenterologie und Hepatologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Deutschland.
Chirurg. 2016 Jun;87(6):514-9. doi: 10.1007/s00104-016-0169-2.
Perihilar cholangiocarcinoma (Klatskin tumor) is a rare tumor entity with an unfavorable prognosis despite optimal treatment.
The aim of the study is to investigate beneficial histopathological features and recommendations for surgery in perihilar cholangiocarcinoma to improve patients' long term survival.
192 patients suffering from perihilar cholangiocarcinoma underwent attempted tumor resection between 1998 and 2008 at our clinic. 50 patients survived more than 2 years. The follow-up ended in December 2013. The resection type, the UICC stage and histopathological features were compared between three groups (2-3-year, 3-5-year and > 5-year survival groups).
The overall 5‑year survival rate of the study groups was 32 %, and even 16 % survived more than 10 years after surgery. Patients with lymph node positive tumors (p = 0.0126) and distant metastasis (p = 0.0376) had the poorest survival rate. Perineural invasion had no significant impact on the overall survival, but patients surviving more than 5 years had the lowest incidence of perineural invasion with 18.75 %. Caudate lobectomy was significantly (p = 0.011) associated with a survival of more than 5 years in our study.
Complete tumor resection with additional caudate lobe resection is associated with long-term survival. Perineural invasion seems to be a negative prognostic factor for long-term survival.
肝门部胆管癌(Klatskin瘤)是一种罕见的肿瘤类型,即便接受了最佳治疗,预后仍不理想。
本研究旨在探究肝门部胆管癌有益的组织病理学特征及手术建议,以提高患者的长期生存率。
1998年至2008年期间,192例肝门部胆管癌患者在我院尝试接受肿瘤切除术。50例患者存活超过2年。随访于2013年12月结束。比较了三组(2 - 3年、3 - 5年和>5年生存组)的切除类型、国际抗癌联盟(UICC)分期及组织病理学特征。
研究组的总体5年生存率为32%,甚至有16%的患者术后存活超过10年。有淋巴结转移的肿瘤患者(p = 0.0126)和远处转移患者(p = 0.0376)的生存率最差。神经周围侵犯对总生存率无显著影响,但存活超过5年的患者神经周围侵犯发生率最低,为18.75%。在我们的研究中,尾状叶切除术与超过5年的生存率显著相关(p = 0.011)。
完整的肿瘤切除联合尾状叶切除与长期生存相关。神经周围侵犯似乎是长期生存的一个负面预后因素。